US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week

renaissancecap...2021-12-18

The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

IAS
2021-12-20
IAS
Not the best time to buy IPO
Kong06
2021-12-19
Kong06
👌
DingDang
2021-12-19
DingDang
Buy!
- Cheekyd:
  like please
Gerinit
2021-12-19
Gerinit
Good
- Cheekyd:
  like please
haircut
2021-12-19
haircut
Market still good
littlekitten
2021-12-19
littlekitten
.

发表看法

317

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1104728154?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-18 12:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104728154","market":"us","top_or_hot":-1,"title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","media":"renaissancecap...","content":"<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">网页链接</a>\n\n</div>\n","source":"lsy1619493174116","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","article_id":"1104728154","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","pubTimestamp":1639803394,"sourceInfo":{"source_id":"lsy1619493174116","name":"renaissancecapital"},"weMediaInfo":null,"summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","collect":0,"end_time":0,"defaultTopTitle":"renaissancecapital.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"美国首次公开募股周报：假期周前6宗首次公开募股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GNTA":0.9,"IMMX":0.9,"IOT":0.9,"VINE":0.9},"content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":693980464,"gmtCreate":1639960618820,"gmtModify":1639960619087,"author":{"id":"3576136694569207","authorId":"3576136694569207","name":"IAS","avatar":"https://static.tigerbbs.com/933fbcc1d9c75b4ff82486f8a48a3e7c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3576136694569207","idStr":"3576136694569207"},"htmlText":"Not the best time to buy IPO&nbsp;","listText":"Not the best time to buy IPO&nbsp;","text":"Not the best time to buy IPO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693980464","repostId":1104728154,"repostType":4,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":699427795,"gmtCreate":1639880341352,"gmtModify":1639880341681,"author":{"id":"3581903045598734","authorId":"3581903045598734","name":"Kong06","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581903045598734","idStr":"3581903045598734"},"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699427795","repostId":1104728154,"repostType":4,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":699420511,"gmtCreate":1639879111500,"gmtModify":1639879111969,"author":{"id":"3553254172092293","authorId":"3553254172092293","name":"DingDang","avatar":"https://static.tigerbbs.com/d2a0c38ce6f3c2661fa15b7d1f52eeaf","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3553254172092293","idStr":"3553254172092293"},"htmlText":"Buy!","listText":"Buy!","text":"Buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699420511","repostId":1104728154,"repostType":4,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7041456,"gmtCreate":1639885656228,"gmtModify":1639885656334,"authorId":4100179725007900,"author":{"id":4100179725007900,"idStr":"4100179725007900","authorId":4100179725007900,"name":"Cheekyd","avatar":"https://static.tigerbbs.com/05e7c6e8bcef8bb9fade899aca08288b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699420511,"type":1,"supId":0,"prevId":0,"content":"like please","text":"like please","html":"like please"}],"langContent":"CN"},{"id":699469796,"gmtCreate":1639877780877,"gmtModify":1639877780985,"author":{"id":"4102323649583470","authorId":"4102323649583470","name":"Gerinit","avatar":"https://static.tigerbbs.com/32f151d5c2b15c07d43c4d7f9f49fbab","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4102323649583470","idStr":"4102323649583470"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699469796","repostId":1104728154,"repostType":4,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7041460,"gmtCreate":1639885673164,"gmtModify":1639885673263,"authorId":4100179725007900,"author":{"id":4100179725007900,"idStr":"4100179725007900","authorId":4100179725007900,"name":"Cheekyd","avatar":"https://static.tigerbbs.com/05e7c6e8bcef8bb9fade899aca08288b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699469796,"type":1,"supId":0,"prevId":0,"content":"like please","text":"like please","html":"like please"}],"langContent":"CN"},{"id":699498280,"gmtCreate":1639872998654,"gmtModify":1639872998739,"author":{"id":"4102455619608180","authorId":"4102455619608180","name":"haircut","avatar":"https://static.tigerbbs.com/664eac8e1f74f7555d093f964e7bab93","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4102455619608180","idStr":"4102455619608180"},"htmlText":"Market still good","listText":"Market still good","text":"Market still good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699498280","repostId":1104728154,"repostType":4,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":699576204,"gmtCreate":1639869622304,"gmtModify":1639869622789,"author":{"id":"3584860762907200","authorId":"3584860762907200","name":"littlekitten","avatar":"https://static.tigerbbs.com/ccd59ff6c96999c839e3b5709cfb00ef","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3584860762907200","idStr":"3584860762907200"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699576204","repostId":1104728154,"repostType":2,"repost":{"id":"1104728154","pubTimestamp":1639803394,"share":"https://www.laohu8.com/m/news/1104728154?lang=&edition=full","pubTime":"2021-12-18 12:56","market":"us","language":"en","title":"US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1104728154","media":"renaissancecap...","summary":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by I","content":"<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer&nbsp;<b>Samsara</b>(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.</p>\n<p><a href=\"https://laohu8.com/S/IOT\"><b>Samsara</b></a> priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.</p>\n<p>Italian solid tumor biotech&nbsp;<a href=\"https://laohu8.com/S/GNTA\"><b>Genenta Science</b></a> upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.</p>\n<p>Wine brand&nbsp;<a href=\"https://laohu8.com/S/VINE\"><b>Fresh Vine Wine</b>&nbsp;</a> priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.</p>\n<p>Micro-cap&nbsp;<a href=\"https://laohu8.com/S/IMMX\"><b>Immix Biopharma</b></a> priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.</p>\n<p>Australia-listed&nbsp;<a href=\"https://laohu8.com/S/BNOX\"><b>Bionomics</b></a> raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.</p>\n<p>Micro-cap satellite developer&nbsp;<a href=\"https://laohu8.com/S/SIDU\"><b>Sidus Space</b>&nbsp;</a> priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.</p>\n<p>14 SPACs went public led by electrification-focused&nbsp;<b>Battery Future Acquisition</b>(BFAC.U) and Investcorp’s&nbsp;<b>Investcorp Europe Acquisition I</b>(IVCBU), which both raised $300 million.</p>\n<p><img src=\"https://static.tigerbbs.com/799a4a1f3d2f8a7ae87a4d79ea13c453\" tg-width=\"481\" tg-height=\"577\" referrerpolicy=\"no-referrer\">Six IPOs submitted initial filings led by leading PE firm<b>TPG</b>(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech&nbsp;<b>Amylyx Pharmaceuticals</b>(AMLX), software firm<b>Justworks</b>(JW), and hypertension biotech&nbsp;<b>CinCor Pharma</b>(CINC) all filed to raise $100 million. Chinese food and beverage supplier&nbsp;<b>Fortune Valley Treasures</b>(FVTI) filed to raise $25 million, and cybersecurity services provider&nbsp;<b>Cerberus Cyber Sentinel</b>(CISO) filed to raise $10 million.</p>\n<p>Three SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Screaming Eagle Acquisition</b>(SCRMU), which filed to raise $750 million.</p>\n<p><img src=\"https://static.tigerbbs.com/d7c4fbba2b60c3e616cb443ad97fd1a9\" tg-width=\"710\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: 6 IPOs debut ahead of the shortened holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 12:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINE":"Fresh Vine Wine, Inc","GNTA":"Genenta Science S.p.A.","IMMX":"Immix Biopharma, Inc","IOT":"Samsara, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89658/US-IPO-Weekly-Recap-6-IPOs-debut-ahead-of-the-shortened-holiday-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104728154","content_text":"The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara(IOT). 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings.\nSamsara priced at the high end to raise $805 million at a $12.4 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22. Samsara finished down 3%.\nItalian solid tumor biotech Genenta Science upsized and priced at the midpoint to raise $36 million at a $208 million market cap. Genenta’s lead candidate, Temferon, is currently in a Phase 1/2a dose-escalation trial in newly diagnosed glioblastoma multiforme patients with unmethylated MGMT gene promoters. The company anticipates completing patient enrollment and treatment by the 2Q22. Genenta finished down 4%.\nWine brand Fresh Vine Wine  priced at the high end to raise $22 million at a $122 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico. Fresh Vine Wine finished down 43%.\nMicro-cap Immix Biopharma priced at the low end to raise $21 million at a $71 million market cap. Immix Biopharma is developing a novel class of tissue-specific therapies in oncology and inflammation. Its lead candidate, IMX-110, is currently in Phase 1b/2a trials for solid tumors in the US and Australia. Immix finished down 20%.\nAustralia-listed Bionomics raised $20 million at an $89 million market cap. Bionomics’ lead candidate, BNC210, is expected to begin its Phase 2 PREVAIL trial for social anxiety disorder by the end of 2021, with topline data anticipated by the end of 2022, and has already started its Phase 2b ATTUNE trial for PTSD, with topline data anticipated in the 1H23. Bionomics finished up 5%.\nMicro-cap satellite developer Sidus Space  priced at the midpoint to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21. Sidus Space finished up 133%.\n14 SPACs went public led by electrification-focused Battery Future Acquisition(BFAC.U) and Investcorp’s Investcorp Europe Acquisition I(IVCBU), which both raised $300 million.\nSix IPOs submitted initial filings led by leading PE firmTPG(TPG), which filed for an estimated $1.5 billion IPO. ALS biotech Amylyx Pharmaceuticals(AMLX), software firmJustworks(JW), and hypertension biotech CinCor Pharma(CINC) all filed to raise $100 million. Chinese food and beverage supplier Fortune Valley Treasures(FVTI) filed to raise $25 million, and cybersecurity services provider Cerberus Cyber Sentinel(CISO) filed to raise $10 million.\nThree SPACs submitted initial filings led by Sagansky and Sloan’s Screaming Eagle Acquisition(SCRMU), which filed to raise $750 million.\n","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":317,"commentSize":17,"repostSize":0,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104728154"}